chr22-41173605-C-T

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_001429.4(EP300):​c.4618-18C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.325 in 1,612,728 control chromosomes in the GnomAD database, including 89,999 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 6240 hom., cov: 32)
Exomes 𝑓: 0.33 ( 83759 hom. )

Consequence

EP300
NM_001429.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.374
Variant links:
Genes affected
EP300 (HGNC:3373): (E1A binding protein p300) This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 22-41173605-C-T is Benign according to our data. Variant chr22-41173605-C-T is described in ClinVar as [Benign]. Clinvar id is 93742.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-41173605-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.476 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
EP300NM_001429.4 linkuse as main transcriptc.4618-18C>T intron_variant ENST00000263253.9 NP_001420.2
EP300NM_001362843.2 linkuse as main transcriptc.4540-18C>T intron_variant NP_001349772.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
EP300ENST00000263253.9 linkuse as main transcriptc.4618-18C>T intron_variant 1 NM_001429.4 ENSP00000263253 P2
ENST00000415054.1 linkuse as main transcriptn.83-4024G>A intron_variant, non_coding_transcript_variant 3
EP300ENST00000674155.1 linkuse as main transcriptc.4540-18C>T intron_variant ENSP00000501078 A2
EP300ENST00000703544.1 linkuse as main transcriptc.*2538-18C>T intron_variant, NMD_transcript_variant ENSP00000515365

Frequencies

GnomAD3 genomes
AF:
0.264
AC:
40153
AN:
151988
Hom.:
6244
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0953
Gnomad AMI
AF:
0.304
Gnomad AMR
AF:
0.265
Gnomad ASJ
AF:
0.303
Gnomad EAS
AF:
0.492
Gnomad SAS
AF:
0.303
Gnomad FIN
AF:
0.275
Gnomad MID
AF:
0.283
Gnomad NFE
AF:
0.342
Gnomad OTH
AF:
0.295
GnomAD3 exomes
AF:
0.303
AC:
75857
AN:
250128
Hom.:
12652
AF XY:
0.309
AC XY:
41853
AN XY:
135422
show subpopulations
Gnomad AFR exome
AF:
0.0907
Gnomad AMR exome
AF:
0.196
Gnomad ASJ exome
AF:
0.298
Gnomad EAS exome
AF:
0.466
Gnomad SAS exome
AF:
0.298
Gnomad FIN exome
AF:
0.291
Gnomad NFE exome
AF:
0.344
Gnomad OTH exome
AF:
0.300
GnomAD4 exome
AF:
0.332
AC:
484654
AN:
1460622
Hom.:
83759
Cov.:
34
AF XY:
0.332
AC XY:
240873
AN XY:
726574
show subpopulations
Gnomad4 AFR exome
AF:
0.0874
Gnomad4 AMR exome
AF:
0.206
Gnomad4 ASJ exome
AF:
0.295
Gnomad4 EAS exome
AF:
0.547
Gnomad4 SAS exome
AF:
0.290
Gnomad4 FIN exome
AF:
0.290
Gnomad4 NFE exome
AF:
0.344
Gnomad4 OTH exome
AF:
0.317
GnomAD4 genome
AF:
0.264
AC:
40149
AN:
152106
Hom.:
6240
Cov.:
32
AF XY:
0.263
AC XY:
19568
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.0954
Gnomad4 AMR
AF:
0.265
Gnomad4 ASJ
AF:
0.303
Gnomad4 EAS
AF:
0.492
Gnomad4 SAS
AF:
0.302
Gnomad4 FIN
AF:
0.275
Gnomad4 NFE
AF:
0.341
Gnomad4 OTH
AF:
0.293
Alfa
AF:
0.291
Hom.:
1829
Bravo
AF:
0.257
Asia WGS
AF:
0.379
AC:
1316
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 11, 2014- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxJul 17, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
11
DANN
Benign
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2076578; hg19: chr22-41569609; COSMIC: COSV54325089; COSMIC: COSV54325089; API